ZARVY

Mignar 50 is a highly effective oral medication for managing Type 2 diabetes, belonging to the alpha-glucosidase inhibitor (AGI) class. It contains Miglitol 50mg, which works by delaying carbohydrate digestion and absorption in the intestines, thereby reducing post-meal blood sugar spikes. This mechanism helps improve glycemic control and supports better insulin efficiency in diabetic patients. Unlike insulin or sulfonylureas, Mignar 50 does not stimulate insulin secretion, making it a safe option with a lower risk of hypoglycemia. It is often prescribed as a monotherapy or in combination with other diabetes treatments like Metformin or DPP-4 inhibitors for enhanced blood sugar regulation. Additionally, due to its impact on glucose absorption, Mignar 50 may contribute to weight stabilization by preventing excessive fat accumulation linked to blood sugar fluctuations.